SEC Form 4 · accession 0001562180-17-000734
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Federici
Officer — Sr. VP & CFO
Period of report
Feb 14, 2017
Accepted (ET)
Feb 16, 2017 · 3:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 14, 2017 | A | 4,623 | $86.93 | A | 211,202 | D | |
| Common StockF2 | holding | — | — | — | 1,038 | I | By Savings Plan | |
| Common StockF2 | holding | — | — | — | 16,927 | I | Non-Qualified Deferred Compensation Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares represent the portion of the Performance Share Unit Award granted in 2014 that have vested for period 13.
- F2Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.